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Abstract
Macrophages display flexible activation states that range between pro-inflammatory (classi-
cal activation) and anti-inflammatory (alternative activation). These macrophage polariza-
tion states contribute to a variety of organismal phenotypes such as tissue remodeling and
susceptibility to infectious and inflammatory diseases. Several macrophage- or immune-
related genes have been shown to modulate infectious and inflammatory disease patho-
genesis. However, the potential role that differences in macrophage activation phenotypes
play in modulating differences in susceptibility to infectious and inflammatory disease is just
emerging. We integrated transcriptional profiling and linkage analyses to determine the
genetic basis for the differential murine macrophage response to inflammatory stimuli and
to infection with the obligate intracellular parasite Toxoplasma gondii. We show that specific
transcriptional programs, defined by distinct genomic loci, modulate macrophage activation
phenotypes. In addition, we show that the difference between AJ and C57BL/6J macro-
phages in controlling Toxoplasma growth after stimulation with interferon gamma and tumor
necrosis factor alpha mapped to chromosome 3, proximal to the Guanylate binding protein
(Gbp) locus that is known to modulate the murine macrophage response to Toxoplasma.
Using an shRNA-knockdown strategy, we show that the transcript levels of an RNA heli-
case, Ddx1, regulates strain differences in the amount of nitric oxide produced by macro-
phage after stimulation with interferon gamma and tumor necrosis factor. Our results
provide a template for discovering candidate genes that modulate macrophage-mediated
complex traits.
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Author Summary
Macrophages provide a first line of defense against invading pathogens and play an impor-
tant role in the initiation and resolution of immune responses. When in contact with path-
ogens or immune factors, such as cytokines, macrophages assume activation states that
range between pro-inflammatory (classical activation) and anti-inflammatory (alternative
activation). Even though it is known that macrophages from different individuals are
biased towards one of the various activation states, the genetic factors that define individ-
ual differences in macrophage activation are not fully understood. Additionally, although
macrophages are important in infectious disease pathogenesis, how individual differences
in macrophage activation contribute to individual differences in susceptibility to infectious
disease is just emerging. We used macrophages from genetically segregating mice to show
that discrete transcriptional programs, which are modulated by specific genomic regions,
modulate differences in macrophage activation. Murine macrophages differences in con-
trolling Toxoplasma growth mapped to chromosome 3, proximal to the Guanylate binding
protein (Gbp) locus that is known to modulate the murine macrophage response to Toxo-
plasma. Using a shRNA-mediated knockdown approach, we show that the DEAD
box polypeptide 1 (Ddx1) modulates nitric oxide production in macrophages stimulated
with interferon gamma and tumor necrosis factor. These findings are a step towards the
identification of genes that regulate macrophage phenotypes and disease outcome.
Introduction
At the cellular level, innate immune cells, such as macrophages, are central to the development
and prevention of infectious diseases. On engagement of surface signaling receptors or pattern
recognition receptors (PRRs) such as toll-like receptors (TLRs), RIG-I-like receptors (RLRs)
and the cytosolic NOD-like receptors (NLRs), by immune factors such as cytokines or con-
served microbial products, macrophages can assume different activation states. The most
extreme of these states are the classical (M1, M(IFNG)) and the alternative (M2, M(IL-4))
states, separated by several intermediate activation states [1–3] (We are following the recently
described macrophage activation phenotype nomenclature [1]). Ultimately, macrophage acti-
vation results in pathogen clearance by downstream antimicrobial effector mechanisms, such
as inflammasome activation, or activation of adaptive immune responses [4–6]. Although the
outcome of macrophage activation is dependent on the stimulus engaged by the PRRs, emerg-
ing empirical data, from both human and mouse studies, indicate that the macrophage genetic
background also plays a significant role.
The initiation of immune responses by macrophages can occur in the presence of pro-
inflammatory cytokines such as interferon gamma (IFNG), while anti-inflammatory cytokines
such as interleukin (IL)-4, and IL-13, prime macrophages for the resolution of immune
responses and tissue repair [7–9]. This macrophage ability to initiate and resolve immune
responses, while important in regulating immunopathology, can be exploited by pathogens to
evade macrophage-associated immunity [10]. Indeed, to disseminate in their hosts most patho-
gens circumvent macrophage-mediated microbicidal mechanisms by modulating macrophage
signaling pathways and activation phenotypes [11–16]. In addition to destroying pathogens,
activated macrophages are important mediators in several inflammatory pathologies, including
atherosclerosis, diabetes and cancer [17]. Studies in mice have linked several macrophage- or
immune-related genes, such as Nramp1/Slc11a1, Icsbp1/Irf8, Csfgm, and Nos2, with the devel-
opment of several infectious diseases, including salmonellosis, toxoplasmosis, and
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leishmaniasis [18–20]. Although the compendium of macrophage- or immune-related genes
that modulate infectious disease pathogenesis is broad, the role of individual differences in
macrophage activation phenotypes in determining individual differences in susceptibility to
infectious disease is just emerging [21–25]. Furthermore, the genetic basis for individual differ-
ences in macrophage activation phenotypes has not been identified. Macrophage activation is
likely modulated by complex gene and metabolite networks that cannot be defined one gene at
a time, thus the difficulty in unraveling the genetics of macrophage activation. This hypothesis
is reinforced by results from genetic perturbation experiments that have revealed multiple
genes that individually modulate macrophage activation phenotypes, including IRF8, PPARG
and AKT2 [26, 27]. Empirical data show that macrophages display distinct transcriptional pro-
grams in response to infectious and inflammatory stimuli [22] and that this macrophage
response differs between genetically segregating individuals [22–25]. Our hypothesis is that
inter-individual differences in susceptibility to infectious disease are partly due to genetic dif-
ferences in the macrophage response to pathogens.
Quantitative trait locus (QTL) analyses have been used to elucidate the complex genetic
basis for many traits in humans and model organisms [28, 29]. However, the region spanned
by individual QTL is often large and encompasses multiple genes, making the transition from
QTL to individual genes influencing disease (quantitative trait gene, QTG) difficult. It has been
shown that differences in the abundance of certain transcripts can explain phenotypic varia-
tions between individuals [30, 31]. Forward genetics approaches that combine traditional QTL
mapping with expression quantitative trait mapping (eQTL; in which case transcript abun-
dance is the quantitative trait) [32] are increasingly being used to successfully transition from
QTL to QTG [33–35]. Traditional QTL analysis will identify the genomic regions affecting
trait variation, while eQTL analysis can help in understanding which genes, pathways, and bio-
logical processes are also under the influence of a given QTL. By examining the relationship
between transcript location, the location of the eQTL and the pleiotropic effects of the eQTL,
tools of systems biology such as network and functional analysis can be used to further delin-
eate the complex genetic interactions modulating complex traits and reconstruct genetic path-
ways that underlie such traits [33–35].
In this study, we used the AXB/BXA recombinant inbred (RI) mice to investigate the rela-
tionship between the macrophage genotype and their response to inflammatory stimuli or
infection with Toxoplasma, an obligate intracellular protozoan parasite. The AXB/BXA mice
are derived from an initial reciprocal cross of AJ (A) and C57BL/6J (B) mice followed by multi-
ple rounds (20) of inbreeding resulting in a stable mosaic of blocks of the parental alleles in
their genomes [36]. These mice have been used to investigate the development and susceptibil-
ity to a variety of infectious and inflammatory diseases [19, 37–40]. Importantly, the parental
strains, AJ and C57BL/6J, differ at key loci that regulate immune responses, including the com-
plement 5 a (C5a) [41] and interleukin 3 receptor alpha (Il3ra) [25, 42]. These mice also exhibit
differences in the amount of IL-10 and tumor necrosis factor (TNF) produced in response to
bacterial infection [43, 44]. Furthermore, the parental AJ and C57BL/6J vary in susceptibility to
a variety of pathogens, including Staphylococcus aureus, Toxoplasma gondii and Trypanosoma
cruzi [38, 44–47]. By linking QTL analyses of defined macrophage phenotypes and macro-
phage transcriptional profiles, captured by high-throughput RNA-sequencing, we have identi-
fied many loci that affect the macrophage response to inflammatory stimuli and infection.
These loci could provide the foundations for further studies in identifying the genetic basis for
the differences in susceptibility to inflammation and infection in these mice. As an example, we
report that differences in nitric oxide (NO) production, in AJ and C57BL/6J macrophages is
due to differences in the expression of the RNA helicase Ddx1.
The Genetics of Macrophage Activation
PLOS Genetics | DOI:10.1371/journal.pgen.1005619 October 28, 2015 3 / 25
Results
AJ and C57BL/6J BMDM differ in their response to infectious and
inflammatory stimuli
Although correlations between genetic variations in immune-related genes and the response to
infectious and inflammatory stimuli have been reported in AJ and C57BL/6J (B6) [19, 43, 44],
the role of specific immune cells in these phenotypic differences are mostly equivocal. There-
fore, we stimulated AJ and B6 bone marrow-derived macrophages (BMDM) with interferon
gamma (IFNG) and tumor necrosis alpha (TNF) (IFNG+TNF) or interleukin 4 (IL4). IFNG
+TNF induces the classical (M(IFNG)) while IL-4 induces the alternative (M(IL-4)) macro-
phage activation phenotypes. Additionally, to mimic activation by bacteria and pathogen-asso-
ciated molecular patterns (PAMPs), we stimulated the macrophages with lipopolysaccharide
(LPS) (a component of gram-negative bacteria), or CpG (a synthetic oligonucleotide), respec-
tively. A summary of the stimulation regimen and the corresponding phenotypes measured is
shown in S1 Table. Next, we captured the macrophage response to the individual stimulus by
measuring M(IFNG) and M(IL-4) markers. For M(IFNG) markers, we measured the amount
of nitric oxide (NO) and IL-12, while for M(IL-4) markers, we quantified the amount of urea (a
by-product of Arginase I enzyme activity), IL-10 and chemokine (C-C motif) ligand 22
(CCL22) (Fig 1). Finally, because: 1) IFNG is indispensable in the resistance to Toxoplasma
gondii [48], 2) Toxoplasma is a master regulator of macrophage signaling pathways [14], and
3) AJ and B6 mice segregate for susceptibility to Toxoplasma [38, 49], we infected non-stimu-
lated or IFNG+TNF-stimulated BMDMwith a strain of Toxoplasma engineered to express fire-
fly luciferase [50] and assessed parasite growth by measuring luciferase activity, which is often
used to approximate Toxoplasma burden in in vitro or in vivo infection models [49–52]. We
observed high amounts of NO and CCL22 in AJ BMDM, while the B6 BMDM produced higher
amounts of IL-12, IL-10 and urea (Fig 1A–1E). Despite producing high amounts of M(IL-4)
markers (urea and IL-10), the B6 BMDM also produced high amounts of an M(IFNG) marker
(IL-12) relative to AJ BMDM. Similarly, the high amount of NO, an M(IFNG) marker, pro-
duced by AJ BMDM was accompanied by high amounts of CCL22, an M(IL-4) marker. This
dual expression of M(IFNG) and M(IL-4) markers is perhaps indicative of complex molecular
modulation of macrophage activation or the heterogeneity of macrophage activation pheno-
types. Consistent with the known resistance of AJ mice to Toxoplasma relative to B6 mice [38,
49], and the divergent BMDM activation phenotypes, Toxoplasma growth in the IFNG+TNF-
stimulated AJ BMDM was significantly reduced compared to its growth in B6 BMDM (Fig 1F).
Thus, the variable susceptibility to Toxoplasma in AJ versus B6 observed in vivo [38, 49] can be
recapitulated in vitro using AJ and B6 BMDM. As such, the AJ and B6 BMDM can be used to
gain insight into the molecular mechanisms that underlie the differences in AJ versus B6 sus-
ceptibility to Toxoplasma. Together, the difference in macrophage response to IFNG+TNF
stimulation, as evidenced by NO (a key toxostatic effector [53, 54]), and the differences in para-
site growth in IFNG+TNF-stimulated BMDM, posit that the variable susceptibility to Toxo-
plasma between AJ and B6 mice is due to innate differences in the macrophage response to the
parasite and/or IFNG+TNF.
The genetic basis for differential macrophage response to infectious and
inflammatory stimuli
The differences in response to infectious and inflammatory stimuli in AJ and B6 mice have a
genetic component [19, 38, 43]. Therefore, having established differences in parasite growth
and activation phenotypes in AJ and B6 BMDM, we sought to establish the genetic basis for
The Genetics of Macrophage Activation
PLOS Genetics | DOI:10.1371/journal.pgen.1005619 October 28, 2015 4 / 25
Fig 1. BMDM fromAJ and B6mice differ in their response to various stimuli. A) Stimulation of macrophages for ~ 18 hrs with IFNG+TNF resulted in
high production of NO by AJ macrophages (black bars), while B) stimulation with LPS led to higher production of IL-12 in C57BL/6J (B6) macrophages (white
bars). C) Stimulation of murine macrophages with LPS or CPG resulted in significantly higher production of IL-10 in B6 macrophages compared to the AJ
macrophages. D) B6 macrophages stimulated with IL-4 produced significantly more urea, compared to AJ macrophages, while LPS stimulation induced low
amounts of urea in both AJ and B6 BMDM. E) AJ macrophages stimulated with CPG or LPS produced significantly higher amounts of the chemokine CCL22
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the differences in macrophage activation and toxoplasmacidal activity between AJ and B6
using the AXB/BXA mice. We stimulated BMDM obtained from 26 age-matched female AXB/
BXA RI mice with IFNG+TNF, IL-4, CpG, or LPS and measured the amount of NO, urea, IL-
12, IL-10, and CCL22 produced. We also infected IFNG+TNF stimulated BMDM with Toxo-
plasma that express luciferase and measured relative parasite growth by measuring luciferase
activity. These phenotypes exhibited a continuous distribution in the RI mice, which is charac-
teristic of quantitative traits (S1A–S1F Fig).
Due to the stable and unique combination of blocks of parental alleles in their genomes, the
AXB/BXA RI mice are particularly suited for quantitative trait locus (QTL) mapping [55].
Therefore, we used the AXB/BXA genetic map (containing 934 informative genetic markers
[56]) in a genome-wide scan in R/qtl [57] to identify the genomic regions that modulate differ-
ences in AJ and B6 BMDM phenotypes. To correct for multiple testing on the 934 genetic
markers, we performed 1000 permutation tests on the individuals relative to their phenotypes
[58] to obtain adjusted p-values for each QTL (Table 1). Parasite growth in the IFNG+TNF-
stimulated BMDMmapped to chromosome 3 (147.7 Mb), proximal to the Guanylate binding
protein (Gbp) locus (142.6 Mb) that is known to modulate the murine macrophage response to
Toxoplasma [59–62]. Even though AJ and B6 BMDM display distinct polarization states fol-
lowing IFNG+TNF or IL-4 stimulation, except for IL-12 and CCL22, we did not observe statis-
tically significant QTL peaks for any of the activation phenotypes. Instead we observed a
suggestive QTL for NO on chromosome 12 (Table 1) and a second QTL for NO on chromo-
some 4 (S2A Fig). The additive QTL for NO also mapped to chromosome 4 (S2B Fig). Similar
to observations in the parental BMDM, the AJ allele at the chromosome 12 QTL was associated
with high amounts of NO (S2C Fig). However, the AJ allele at the chromosome 4 QTL was
compared to B6 macrophages. F) The IFNG+TNF stimulated macrophages have increased toxoplasmacidal activity, which is slightly reduced in the
presence of aminoguanidine (AG), an inducible nitric oxide synthase inhibitor. Where there was no detectable amount of cytokine/chemokine measured,
including in all control (non-stimulated) BMDM, we do not include cytokine/chemokine data in the figures. Three independent replicates; Mean (SD) *
p < 0.05 (Student’s t-test).
doi:10.1371/journal.pgen.1005619.g001
Table 1. Linkage analysis of AJ and C57BL/6J phenotypic differences using the recombinant inbred AXB/BXAmice.
Stimulation Phenotype QTL position (Chr) QTL peak position (Mb) LOD Adjusted p value Gene location
LPS CCL22 8 109.50 6.6 0.001 Ccl22, 8 (94.94–94.75)
LPS IL-12 11 37.48 5.5 0.006 IL12p40, 11 (44.40–44.41)
IFNG+TNF Nitric Oxide 12 9.21 2.9 0.06* Nos2, 11 (78.92–78.96)
IL-4 Arginase activity 10 21.12 3.8 0.08* Arg1, 10 (24.91–24.92)
LPS IL-10 1 76.52 3.3 0.06* Il10, 1(131.0–131.0)
IFNG+TNF Parasite growth 3 147.75 4.1 0.08* -
LPS Arginase activity 1 22.1 2.1 0.77 Arg1, 10 (24.91–24.92)
CPG IL-10 1 40.6 2.9 0.16 Il10, 1(131.0–131.0)
CPG CCL22 X 99.93 0.20 Ccl22, 8 (94.94–94.75)
Control Parasite growth 3 147.75 2.7 0.33 -
IFNG+TNF+AG Parasite growth 3 147.75 3.4 0.10 -
IFNG+TNF+AG NO 15 87.67 2.5 0.46 Nos2, 11 (78.92–78.96)
QTL were deemed significant at an adjusted p< 0.01 calculated after 1000 permutations in R/qtl. Shown are the individual phenotypes and the
corresponding adjusted p-values for each LOD score.
* = Suggestive QTL. Gene location indicates the physical location, chromosome followed by position (Mb) in parenthesis, of the gene coding for the
measured phenotype.
doi:10.1371/journal.pgen.1005619.t001
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associated with low amounts of NO (S2D Fig). Although mapping in cis to Arg1 on chromo-
some 10, the QTL for the amount of urea did not reach statistical significance. Nevertheless,
the allele effect at the suggestive urea QTL was consistent with the parental allele effect on urea.
Finally, we selected the top 2 QTL for each phenotype (where there was marginal difference
between the LOD scores for the second and third largest QTL, we picked both) and grouped
the BMDM based on the genotypes at each QTL. We then estimated the QTL inheritance pat-
tern by comparing the values for the corresponding phenotype amongst the genotypes using a
one-way ANOVA with Tukey’s-Post-test (StatPlus, AnalystSoft Inc) [63] (Table 2).
Divergent genomic loci modulate macrophage transcriptional response
to infectious and inflammatory stimuli
Discrete transcriptional programs modulate the response of immune cells, including macro-
phages, to stimuli such as pathogens and immune factors [24, 31, 33]. As such transcriptional
profiles can be used to gain insight into the intricate and incipient molecular networks that
modulate complex traits, such as macrophage activation [24, 34, 64, 65]. Consequently, we
investigated whether specific transcriptional programs modulate the differential activation of
AJ and B6 BMDM. To do this, we performed high throughput RNA-sequencing (RNA-seq) on
BMDM obtained from the same 26 age- and sex-matched AXB/BXA mice described above and
Table 2. QTL inheritance and allele effects on different traits in AXB/BXA BMDM.
Chr Stimulation Trait Marker AA (Mean) BB (Mean) P-value
6 LPS CCL22 rs3695724 409.2 786.8 1.8e-3
8 LPS CCL22 rs6182338 874.8 334.0 8.8e-8
18 LPS CCL22 rs3720827 806.7 450.5 3.5e-3
11 LPS IL-12 rs13480972 56.7 199.8 1.1e-6
16 LPS IL-12 rs4188825 172 69.1 2.3e-3
17 LPS IL-12 rs3684732 48.7 145.2 1.9e-3
4 IFN+TNF Nitric Oxide rs3723703 9.9 15.1 1.3e-3
12 IFN+TNF Nitric Oxide rs6176675 14.7 9.2 4.6e-4
1 IL-4 Arginase activity mCV23695025 2.5 2.1 9.4e-4
10 IL-4 Arginase activity CEL-10_2111704 1.5 1.2 1.1e-1
1 LPS IL-10 mCV24115911 204.8 89.9 3.0e-4
4 LPS IL-10 gnf04.019.134 114.4 180.3 4.2e-1
2 IFN+TNF Parasite growth D2Mit5 2.4 x 105 2.7 x 105 1.9e-1
3 IFN+TNF Parasite growth gnf03.151.552 2.2 x 105 3.1 x 105 2.8e-5
1 LPS Arginase activity mCV23695025 2.0 1.6 3.2e-3
5 LPS Arginase activity rs13478413 1.8 2.1 1.4e-2
3 Control Parasite growth gnf03.151.552 8.9 x 105 1.2 x 106 1.4e-3
13 Control Parasite growth rs13481799 1.0 x 106 8.1 x 105 7.1e-3
3 IFN+TNF+AG Parasite growth gnf03.151.552 1.9 x 105 3.0 x 105 6.1e-3
X IFN+TNF+AG Parasite growth CEL-X_66015326 2.7 x 105 2.0 x 105 8.2e-3
1 CPG IL-10 rs3677272 3.0 x 103 2.0 x 103 1.2e-3
10 CPG IL-10 rs6197175 3.3 x 103 2.2 x 103 1.0e-3
X CPG CCL22 CEL-X_94143306 253.6 96.3 4.7e-3
2 CPG CCL22 rs3726974 270.6 106.2 5.3e-3
AA = Homozygous AJ allele; BB = Homozygous B6 allele. BMDMs were grouped based on their genotypes at the marker on the QTL peak. P-values
were corrected for multiple testing (26 individuals) using the Bonferroni test.
doi:10.1371/journal.pgen.1005619.t002
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their progenitors (28 samples in total), before (resting, controls) and after infection with Toxo-
plasma or stimulation with IFNG+TNF, or CpG. For each sample we generated at least 100
million paired-end reads, except for the IFNG+TNF-stimulated BMDM samples that were
sequenced on a single end. Although all the samples were sequenced once, due to the unique
recombination of the parental alleles and homozygosity at each of the informative genetic
markers (934), there are at least 4 replicates (the minimum number of mice having the same
allele at each marker) for each marker. Thereafter, we processed the RNA-seq data as previ-
ously described [25]. Briefly, we aligned the RNA-seq reads to the mouse reference genome
(NCBI build GRcm38, downloaded from Illumina iGenomes; https://support.illumina.com/
sequencing/sequencing_software/igenome.html) using TopHat [66]. To avoid read alignment
bias due to sequence polymorphisms between AJ and B6 genomes, we made a synthetic refer-
ence genome in which all the polymorphic nucleotides between AJ and B6 were converted to a
neutral nucleotide [67]. However, and consistent with a recent report [68], allele bias did not
significantly affect read alignment to the genome. On average, about 70% of reads in each sam-
ple uniquely mapped to the synthetic genome, which was about 1% less than the number of
reads uniquely aligned to the iGenome. Henceforth, unless otherwise stated, all RNA-seq data
presented herein were processed using the synthetic genome. Transcript abundance was esti-
mated using Cufflinks [69] and reported as fragment per kilobase exon per million reads
(FPKM).
Next, using the FPKM values from each of the 26 RI BMDM and the corresponding AXB/
BXA genetic map, we mapped the genomic loci that modulate gene expression (expression
QTL, eQTL) [32] using R/qtl [57]. As previously described [25], we performed 1000 permuta-
tions to correct for multiple testing across the 934 informative genetic markers in the AXB/
BXA cross. Next, we used a false discovery rate (FDR) 10%, calculated in the qvalue package
[70], to correct for multiple testing on the transcripts and to nominate significant eQTL.
Finally, to allow for meaningful comparisons, we only included in the downstream analyses,
for each stimulation condition, eQTL for transcripts with an average FPKM 5 across the 26
RI BMDM. The linkage analyses and the subsequent filtering steps were performed separately
in resting, IFNG+TNF-stimulated, CpG-stimulated, and Toxoplasma-infected BMDM and
identified, 131, 367, 688 and 1008 significant eQTL, respectively, dispersed throughout the
genome (Fig 2A and 2B and S1A–S1D Dataset). Thus, consistent with previous studies [24,
71], the genetic background influences macrophage gene expression profile. Importantly the
different stimuli induced transcriptional programs that were modulated by distinct eQTL hot-
spots, which can be exploited to unravel the complex molecular networks that regulate macro-
phage activation states.
QTL hotspots are enriched for biological processes and putative
regulators that modulate the expression of multiple genes
Variable gene expression can be due to sequence or structural variations close to (cis) or further
removed from (trans) the gene itself, such as polymorphism in the promoter regions or at a dis-
tal transcription factor, respectively. Consequently, relative to the physical location of the cor-
responding gene, an eQTL can be categorized as either cis or trans. Thus, we designated eQTL
that co-localized within a 10 Mb genomic window with the corresponding gene as cis and all
other eQTL as trans [72]. Except for the Toxoplasma-infected BMDM (407 cis vs. 601 trans),
most of the eQTL were located in cis in: resting (99 cis vs. 32 trans), IFNG+TNF-stimulated
(194 cis vs. 173 trans), and CpG-stimulated (482 cis vs. 206 trans) BMDM (S1A–S1D Dataset).
Suppose a common locus was to modulate the expression of multiple genes in trans, then in
linkage analysis, we should expect the eQTL for these genes to co-localize in the vicinity of the
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Fig 2. The transcriptional response in BMDM is regulated by stimulation-specific trans-loci. Expression quantitative trait loci (eQTL) in the RI mice
were mapped in A) non-stimulated, B) IFNG+TNF-stimulated, C) Toxoplasma-infected, and D) CpG-Stimulated BMDM. Each dot represents a single eQTL
(transcript). Significant eQTL located 10 Mb from the start of the physical location of the corresponding gene were designated as cismapping (diagonal
lines). All other eQTL were designated as trans-mapping (vertical lines). eQTL significance was calculated after 1000 permutations and reported at genome-
wide thresholds corresponding to FDR 10%. Red spots identify genes mapping to a trans-eQTL hotpot (trans-band).
doi:10.1371/journal.pgen.1005619.g002
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common locus forming a trans-eQTL hotspot (trans-band). Indeed, similar to previous studies
[23, 24, 73], and indicative of a common variant regulating the expression of multiple genes in
trans, we detected trans-eQTL hotspots, within a 10 Mb window, in all the samples (Fig 2A
and 2B and S1A–S1D Dataset). Because it is possible for eQTL to co-localize by chance alone,
we used Bonferroni-corrected p-values and Poisson distribution to compute the number of
trans-eQTL that can co-localize in a 10 Mb genomic window by chance. Using these cutoffs,
we identified 2, 3, 5, and 15 trans-eQTL hotspots in the resting, IFNG+TNF-stimulated, CpG-
stimulated, and Toxoplasma-infected BMDM, respectively (S1A–S1D Dataset).
Previously, it was reported that eQTL that localize close to the physical location of the rele-
vant gene (cis-eQTL) are a consequence of single nucleotide polymorphisms (SNPs) [72] or
larger structural variants (SV), such as insertions and deletions. Thus, we investigated the
nucleotide sequence in a 2000 bp window upstream and downstream of the transcription start
site (TSS) of all significant eQTL. Consistent with these reports, we found that most cis-eQTL
were associated with genes reported to have structural or sequence variations within 2000 bp
upstream or downstream of their TSS [74, 75]. That is, in control BMDM we found 89 out of
99 (Hypergeometric test P2.3e-7); in the IFNG+TNF-stimulated BMDM we found 156 out of
196 (Hypergeometric test P3.3e-10); in the CpG-stimulated BMDM we found 422 out of 482
(Hypergeometric test P3.8e-23); and in the Toxoplasma-infected BMDM we found 369 out of
407 (Hypergeometric test P1.6e-49) cis-eQTL with polymorphisms within 2000bp upstream
or downstream of TSS. These included genes with known immunological functions such as
Gbp1, Gbp2, Irak4 and Srebf1.
As indicated above, trans-eQTL hotspots can be due to transcriptional regulation of several
genes by a common genetic variant [76], such as a polymorphic or differentially expressed
transcription factor, enhancer or repressor. Alternatively, a trans-band can be a result of a dif-
ferentially expressed or polymorphic signaling protein, such as a cell surface receptor, that
could lead to differential activation of transcription factors and the genes downstream of these
transcription factors. Consequently, the eQTL localizing at the trans-eQTL hotspot are likely
to be enriched for binding sites for a common transcription factor(s) physically located at the
trans-eQTL-hotspot, biological function, or signaling pathway. Therefore, we used gene ontol-
ogy (GO) [77] and rVISTA [78] to functionally characterize and search for transcription factor
binding site enrichment in each of the eQTL in the different trans-hotspots (Table 3). We
found that the three largest trans-bands in the Toxoplasma infected BMDMmapped to loci
containing genes with either known or putative roles in macrophage inflammatory or meta-
bolic processes, which are important host responses against intracellular pathogens. For
instance the trans-band on chromosome 13 (117.1–127.8 Mb) overlapped docking protein 3
(Dok3), chemokine (C-X-C motif) ligand 14 (Cxcl14), and AU RNA binding protein/enoyl-
coenzyme A hydratase (Auh), which are known to regulate various aspects of cellular inflam-
matory and metabolic processes [79–81]. Indeed, this trans-band was enriched for, among oth-
ers, “natural killer cell mediated immunity”. Similarly, the trans-band in the IFNG+TNF-
stimulated BMDM on chromosome 15 (89.6–96.6 Mb), which was enriched for “regulation of
leukocyte mediated immunity”, overlapped the interleukin-1 receptor-associated kinase 4
(Irak4), known to regulate the immune response to a variety of infectious and inflammatory
stimuli [18, 82, 83]. Furthermore, Irak4 contains genetic insertions and deletions in AJ relative
to the reference B6 mouse strain [84]. Thus, the trans-bands are functionally enriched in bio-
logically relevant processes and can potentially reveal novel regulators and insight in the com-
plex gene interactions that modulate macrophage response to exogenous stimuli.
To identify putative regulators for the trans-bands, which can be variable transcription fac-
tors or signal transducers, we identified genes that were expressed (average FPKM5), were
physically located within 10 Mb on either side of the trans-eQTL hotspot, and were
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differentially expressed or had non-synonymous (NS) polymorphisms in AJ versus B6 mice.
As an example, the chromosome 15 trans-band (between 79.7–99.7 Mb) contained 81
expressed coding and non-coding genes, 5 of which contained non-synonymous SNPs and 8
exhibited differential expression that mapped in cis. Of these genes, we considered Plxnb2,
Irak4, and Apobec3 to be good candidates since they are known to be involved in immune
response pathways [82, 85, 86], similar to the functional enrichment observed for the chromo-
some 15 trans-band. Additionally, these genes are polymorphic in AJ compared to B6. Due to
insertions and deletions [87] and its function as an immune signaling adaptor, we considered
Irak4 to be a strong candidate regulator for the chromosome 15 trans-band. Hence, we used
shRNA to knockdown Irak4 in the IFNG+TNF-stimulated macrophages. Enrichment analysis
on the perturbed genes following Irak4 knockdown revealed an overrepresentation (p = 0.005)
of several chromosome 15 trans-eQTL (Table 4). shRNA-knockdown of the other putative
candidate genes identified in this study did not perturbed most of the chromosome 15 trans-
band eQTL (S1E Dataset), indicative of a specific effect of Irak4 knockdown on this trans-
band.
Leveraging eQTL analysis to identify candidate genes that modulate
macrophage response to exogenous stimuli
Transcriptional networks capture the connectivity between genes modulating complex pheno-
types and may provide a means to unravel the molecular mechanisms underlying complex
traits. Because cis genetic variants account only for the phenotypes related to the gene they
modulate, we reasoned that they are not good prototypes to illustrate how transcriptional, link-
age and network analyses can be leveraged to systematically elucidate the genetic basis of a
complex trait. Therefore, we used trans genetic variants, which potentially modulate multiple
phenotypes, and followed a step-wise procedure [34] to identify the relationship between tran-
script levels, QTL, and BMDM phenotypes. First, to gain insight into the transcriptional archi-
tecture that modulate macrophage response to stimuli, we constructed gene co-expression
network modules for each macrophage stimulation condition using the topological overlap
Table 3. Functional enrichments in the large trans-eQTL hotspots in AXB/BXAmacrophages following IFNG+TNF-stimulation, CpG-stimulation,
or Toxoplasma-infection.
Stimulation Trans-band Functional enrichment Adjusted P-value Enriched TF P-value
IFNG+TNF 12 (4.4–13.1) Purine metabolism 5.72e-05 E2f6 0.0008
Nitrogen compound metabolic process 2.95e-05 Creb 0.0001
CpG X (139.6–141.1) Histone H3-K4 acetylation 1.80e-03 Sp1 4.92e-05
Positive regulation of nucleic acid-templated transcription 7.91e-03
Toxoplasma 2 (161.5–168.3) Negative regulation of histone H3-K27 methylation 2.04e-02 Sp1 1.05e-18
Positive regulation of purine nucleotide catabolic process 5.11e-02 Egr1
Zfp148 4.16e-15
1.40e-15
10 (117.1–127.8) Leukocyte differentiation 2.31e-04 Zscan10 6.20e-08
Positive regulation of protein deacetylation 2.97e-03 Hif1
Xbp1 1.94e-05
5.37e-04
13 (47.0–57.7) Fc-gamma receptor signaling 2.10e-04 Elk3 5.53e-09
Natural Killer cell mediated immunity 1.83e-03 Etv5
Ets2 1.80e-05
5.15e-04
doi:10.1371/journal.pgen.1005619.t003
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matrix (TOM) in the weighed gene co-expression network analysis (WGCNA) program [88].
Next, using the eigenvalues for each module, we made correlations between each module and
macrophage phenotypes. As proof of principle, we used this approach to nominate candidate
genes that modulate the amount of NO produced in IFNG+TNF-stimulated BMDM. Because
the amount of NO varied in the BMDM after IFNG+TNF, we correlated the co-expression
modules with the amount of NO produced in the IFNG+TNF-stimulated BMDM (S3 Fig).
Subsequently, we identified 4 modules (identified as white, light yellow, blue, and tan) that
showed significant (P 0.01) correlation with NO levels (S3 Fig). It is important to note that,
apart from being arbitrary identifiers for each module, the color code used to name each mod-
ule reveals no further information. Each module, however, contains co-expressed genes (i.e.
genes that exhibit transcriptional correlation across the 26 IFNG+TNF-stimulated BMDM). Of
the 4 modules, the “white” module showed the greatest association with NO, hence we used it
to illustrate our approach. Because the module-trait relationship is based on the correlation of
the module eigenvalue with the amount of NO, not all the genes in the module will show signif-
icant association with the trait (amount of NO produced in the BMDM). Therefore, we further
filtered the genes in the “white” module based on their individual relationship with NO (gene
significance) (S1F Dataset). Expectedly, the eQTL for most of the genes in the module were
localized on chromosome 12 and chromosome 4, the locations for NO QTL. To identify the
potential regulator for cellular amounts of NO, we reasoned that if two genetic traits are both
modulated by the same genetic variant, then the QTL for the two traits will co-localize at the
common genetic variant [34]. Therefore, to further narrow down the significant genes and to
identify the transcriptional network that likely modulate genetic differences in cellular amounts
of NO produced after IFNG+TNF-stimulation, we searched for genes with eQTL that over-
lapped with the NO QTL on chromosome 12 (4.4–13.1 Mb) and found 11 eQTL (S1F Dataset).
These eQTL were functionally enriched for “oxidoreductase activity” (p = 8.322e-04) and
“nitrogen compound metabolism” (p = 1.345e-03) in gene ontology.
Because the common regulator for both NO levels and the chromosome 12 trans-band can
be a polymorphic or differentially expressed transcription factor or signaling receptor physi-
cally located at the chromosome 12 trans-band locus, we narrowed the putative regulators by
searching for cis-eQTL or expressed polymorphic genes at the chromosome 12 locus. Ddx1, a
Table 4. Genes from the chromosome 15 trans-band in IFNG+TNF-stimulated BMDM that were perturbed by at least 2 fold after Irak4 knockdown
and IFNG+TNF stimulation of murine BMDM.
Gene Id Fold change Biological process
Pcdh7 2.40 Cell adhesion
Siglec1 2.16 Endocytosis
Aim1 2.46 -
B4galt6 2.64 Sphingolipid biosynthetic process
Slc37a2 2.18 Glycerol-3-phosphate metabolic process
Rgl1 3.22 Small GTPase mediated signal transduction
Slc16a10 2.25 Transmembrane transport
Cd72 3.34
Cd300lb 2.66
5430435G22Rik 2.50 Negative regulation of toll-like receptor 4 signaling pathway
Tlr9 2.20 Toll-like receptor signaling pathway
Cd24a 2.84 Regulation of cytokine-mediated signaling pathway
Arhgap18 2.28 Signal transduction
Irak4 -2.16 Cytokine-mediated signaling pathway
doi:10.1371/journal.pgen.1005619.t004
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transcriptional regulator of cell cycle, maps in cis at this locus, and was considered a putative
candidate for NO. Additionally, we used the Transcriptional Regulation Inference from Genet-
ics of Gene Expression (Trigger) program [89] to establish the causal relationship between NO
and the genes on chromosome 12, including Ddx1. Trigger utilizes randomized genetic back-
grounds and phenotypes to test for causality between phenotypes that are linked to the same
locus e.g. Ddx1 and NO. Of the chromosome 12 genes, only Ddx1 exhibited a minimum p-
value (0.05) for causal relationship. As expected, the reciprocal analysis did not show NO or
any of the chromosome 12 trans-eQTL as causal for Ddx1 differential expression. Indeed,
shRNA-mediated knockdown of Ddx1 in immortalized B6 macrophages resulted in an increase
in the amount of NO produced after IFNG+TNF-stimulation (Fig 3). Similar to NO, Ddx1
transcript abundance in IFNG+TNF-stimulated macrophages mapped to two loci on chromo-
some 4 and 12. However, Ddx1 transcript abundance exhibited an inverse relationship with the
amount of macrophage NO at both loci (S4A–S4E Fig). Thus, we concluded that the expression
of Ddx1, which is higher in B6 compared to AJ BMDM, inhibited NO production in the B6
macrophages.
Due to the important role macrophages play in the pathology of various intracellular patho-
gens [90], we investigated whether there were overlaps between our trans-eQTL hotspots and
other disease QTL in the AXB/BXA RI mice available in webQTL [91] and found several
(S1A–S1D Dataset). For example the QTL for Listeria monocytogenes proliferation, which is
attributed to macrophage inflammatory response [92], and susceptibility to hepatitis virus [93]
overlapped the trans-eQTL hotspots on chromosome 15 and 7, respectively, in the IFNG
Fig 3. shRNA-mediatedDdx1 knockdown in C57BL/B6J immortalized macrophages relieves NO inhibition. Fold knockdown of Ddx1 and fold change
in NO levels are relative to the Ddx1 expression and the amount of NO in cells transduced with control shRNA (LacZ), respectively. Knocking down E2f6, the
other candidate gene at this locus, did not affect the amount of NO produced. Shown are values of NO (μM) fold change obtained from two independent
experiments using three different shRNA constructs. The knockdown level is indicated by the black triangles. Fold knockdown was calculated using the
2deltadeltaCtmethod. The shRNA transductions and NOmeasurements were done in 3 independent replicates.
doi:10.1371/journal.pgen.1005619.g003
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+TNF-stimulated macrophages. Considering that IFNG+TNF is important in the pathogenesis
of Listeria and Hepatitis infections [94–96], it is likely that these trans-bands harbor genes that
modulate the outcome of infection with these and other pathogens.
Discussion
The activation of macrophages, in response to stimuli such as microbial components or
immune factors, into the broadly defined classical, M(IFNG), and alternative, M(IL-4), pheno-
types, determines whether they initiate or resolve immune responses. As gatekeepers against
invading pathogens, the macrophage activation phenotype is essential in determining the per-
sistence or resolution of infection. Thus, the hypothesis is that for infection to persist, the path-
ogen has to “trick” host macrophages to assume the “wrong” activation state and that variation
in susceptibility to infection between hosts is due to genetic differences in macrophage
response to the pathogen. Indeed empirical evidence shows that many pathogens can alter the
macrophage activation to a phenotype that is favorable for its replication and persistence. For
example, virulent strains of the intracellular parasite Toxoplasma gondii, which is vulnerable to
M(IFNG) macrophages, induces the M(IL-4) phenotype in macrophages [12, 14, 97]. Similar
observations have been made in leishmaniasis, in which the extent of macrophage modulation
is dependent on the host [98]. On the other hand, macrophages from genetically segregating
hosts have been shown to exhibit differential activation states, as captured by transcriptional
and cytokine profiles [21, 71, 99–101]. Despite these documented pathogen-macrophage inter-
plays and the variable inter-host macrophage activation phenotypes, the genetic basis for indi-
vidual differences in macrophage polarization is just emerging. We describe differential
activation of macrophages from the genetically segregating AJ and C57BL/6J (B6) mouse
strains, which we have linked to the variable response to the obligate intracellular parasite,
Toxoplasma gondii. Our in vitromodel, which obviates the interference by other immune cells
and involves naïve bone-marrow derived macrophages as opposed to elicited peritoneal macro-
phages, indicates that when stimulated with equal amounts of cytokines, AJ-derived macro-
phages produce a stronger M(IFNG) phenotype relative to B6 (as measured by NO).
Additionally, we used a panel of genetically diverse recombinant inbred (RI) mice, derived
from AJ and B6 mice, to investigate the specific loci responsible for this variable macrophage
activation and the associated phenotypes.
In mice, nitric oxide (NO) production and L-Arginine metabolism are often used to define
the M(IFNG) and M(IL-4) macrophage activation phenotypes, respectively [100, 102]. While
the cellular levels of these factors vary between genetically divergent individuals and are known
to contribute to the differential response to infection [101, 103, 104], the genetic loci that pre-
dispose macrophages to either the M(IFNG) or M(IL-4) phenotypes are not known. The gen-
eral assumption is that a single locus will determine whether individual macrophages assume
the M(IFNG) or M(IL-4) state. Results from the current study contradict this assumption and
suggest that macrophage activation, as measured by levels of NO, IL-12, CCL22, IL-10 and
Arginase I activity, is modulated by several loci, some with antagonistic effects. While the lim-
ited number of mice available from AXB/BXA RI line may partly explain the lack of statistically
significant QTL for most of the macrophage phenotypes in this study, we submit that the
genetic factors that modulate macrophage polarization form complex interaction networks
that are not linked to a single locus. This conclusion is supported by the identification of two
loci with contrasting effect on NO levels, the high levels of IL-12 and urea in B6 BMDM, and
the high levels of NO and CCL22 in AJ BMDM. Furthermore, our observation of significant
QTL peaks for IL-12 and CCL22 portends that the complex regulation of other phenotypes,
such as NO, rather than the few number of mice, maybe the reason for the insignificant QTL
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peaks. Apart from the individual macrophage activation phenotypes, we did not observe the
convergence of all the M(IFNG) (IL12, NO) at a single locus and the M(IL-4) phenotypes
(IL10, CCL22 and urea) at another locus, instead each phenotype localized to a unique locus,
again reinforcing the complex molecular circuits that modulate the M(IFNG) and M(IL-4)
macrophage states. Although, the B6 mice carry a dominant negative mutation in the Slc7a2
gene, which is involved in L-Arginine transport and is postulated to contribute to the differen-
tial metabolism of L-Arginine in B6 relative to other mouse strains such as BALB/c [105], the
QTL for L-Arginine metabolism did not localize to chromosome 8, which is the physical loca-
tion of Slc7a2. Instead, the QTL for urea (a measure of Arginase activity) mapped to chromo-
some 10, proximal to Arg1, while the QTL for NO mapped to chromosome 12, respectively. It
is plausible that both the transport and metabolism of L-Arginine contribute to the difference
in urea and NO production in AJ and B6, hence the lack of significant QTL for these traits.
Modulation of host cellular signaling and transcriptional pathways by Toxoplasma is known
to aid in immune evasion by the parasite and is achieved via the secretion of polymorphic effector
proteins localized in the rhoptry and dense granule organelles [37, 106–108]. Specifically, the
secretion of the polymorphic dense granule protein (GRA15) by the avirulent type II, and rhop-
try kinase (ROP16) by the virulent type I Toxoplasma strains, is known to elicit classical and
alternative macrophage activation, respectively [12]. Additionally, the secretion of these two
Toxoplasma effector proteins is known to modulate intestinal pathology in the susceptible B6
mice [37]. However, to the best of our knowledge, the potential role of macrophages in Toxo-
plasma-induced intestinal pathology has not been shown. Furthermore, even though AJ and B6
are known to diverge in their response to in vivo Toxoplasma infection phenotypes, there has
been no study showing that this variable response is due to a differential response of their macro-
phages to either IFNG or to the parasite itself. Together, the current study and our previous work
[49], provide compelling evidence that macrophages may play an important role in Toxoplasma
pathology. We postulate that alternative macrophage activation by Toxoplasma [12], and the dif-
ferential AJ and B6 macrophage response to Toxoplasma and IFNG+TNF, provide the intersec-
tion of host-parasite interaction that harbors candidate genes mediating murine toxoplasmosis.
Toxoplasma virulence appears to be related to its ability to skew macrophages towards alternative
activation, which is abetted in susceptible animals, such as B6 mice.
In conclusion, our findings provide an extensive genetic analysis of the macrophage signal-
ing processes in response to exogenous stimuli. Because activation of macrophages by IFNG
and/or TNF confers resistance to a wide range of intracellular pathogens and human diseases,
and because susceptibility loci for some of these phenotypes overlap, it is expected that this
study will provide a framework to help identify candidate genes that mediate some of these dis-
ease phenotypes.
Material and Methods
Ethics statement
All animal experiments were performed in strict accordance with National Institutes of Health
Guide for the Care and Use of Laboratory Animals and the Animal Welfare Act. The Massachu-
setts Institute of Technology Committee on Animal Care (assurance number A 3125–01) approved
all protocols. All mice were maintained in specific pathogen-free conditions and euthanasia was
performed in controlled CO2 chamber as approved by the MIT Animal Care Committee.
Primary bone marrow derived macrophages and parasites
Bone marrow-derived macrophages (BMDM) were obtained from 6–8 weeks old AJ, C57BL/6J
and 26 female AXB/BXA recombinant inbred mice (Jackson Laboratories). Marrow cells were
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obtained from each mouse by flushing the femur and tibia with cold phosphate buffered saline
(PBS; GIBCO-Invitrogen). The cells were then centrifuged at 500 x g for 5 minutes at 4°C and
re-suspended in 4 ml red cell lysis buffer (Sigma) and incubated on ice for 5 minutes. Next, the
cells were passed through a 70 μm cell strainer (BD Biosciences) and centrifuged at 500 x g for
5 minutes at 4 °C. The cells from each mouse were subsequently grown on four 10 cm non-tis-
sue culture petri dishes (Corning) in Dulbecco's modified Eagle's medium (DMEM; GIB-
CO-Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBS; HyClone), 2
mM L-glutamine, 1 mM sodium pyruvate, 1X MEM nonessential amino acids, and 50 μg/ml
each of penicillin and streptomycin. To differentiate the cells into macrophages, the DMEM
was conditioned with 20% L929 cell supernatant (containing GM-CSF (40 ng/ml), hereafter
20% L929). After incubating the cells at 37°C and 5% CO2 for 3 days, the non-adherent cells
were pipetted into 50 ml tubes and centrifuged at 500 x g for 5 minutes at 4°C and seeded in
new 10 cm petri dishes. Simultaneously, the old 10 cm petri dishes were topped up with fresh
media supplemented with 20% L929 i.e. in the end, for each mouse there were 8 petri dishes.
After further incubation at 37°C and 5% CO2 for 4 days, the BMDM were harvested and stored
in liquid nitrogen (5 million cells/ aliquot). The BMDM yield for each mouse strain ranged
between 60–150 million cells, with the B6 mouse consistently producing more cells. This proto-
col has previously been shown to yield pure (>99%) macrophages [12]. A Pru (type II) Toxo-
plasma gondii strain engineered to express firefly luciferase and GFP (Pru ΔHXGPRT A7)
[109], maintained in the laboratory by serial passage on Human Foreskin Fibroblasts (HFF),
was used for all infections.
Immortalized macrophages
To immortalize macrophages, we used J2 recombinant retrovirus [110] produced from
ψCREJ2 cells (a generous gift from John MacMicking, Yale University School of Medicine).
The J2-expressing cells were grown to confluency in DMEMmedium supplemented with 10%
FBS (D10). The medium containing retroviral particles was collected and passed through
0.45 μM low protein-binding filters (Millipore). In parallel, 5 x 106 primary BMDM from AJ
and C57BL/6J, obtained as described above, were thawed and grown for 2 days in DMEM
medium supplemented with 10% FBS and 20% L929. After 2 days, the medium was replaced
with the filtered J2-retrovirus-containing medium supplemented with 50% L929. After 24 hrs,
the media was replaced with fresh D10 medium supplemented with 25% L929. Media was sub-
sequently changed after every 24hrs with concomitant reduction in L929 until 10% L929 con-
centration was reached. Immortalized cells were harvested and stored in liquid nitrogen until
use.
In vitromeasurements
Unless otherwise stated, a total of 104 /well immortalized BMDM (iBMDM) or 105 /well pri-
mary BMDM were used in all the in vitro assays. Unless stated otherwise, before stimulation or
infection, the primary BMDM or iBMDM were seeded overnight in D10 supplemented with
20% L929. Cellular nitric oxide levels were measured using the Griess reagent procedure on
supernatant from non-stimulated or stimulated cells. Arginase activity was measured by quan-
tifying the amount of urea as previously described [111]. Briefly, L-arginine was added to cell
lysates and incubated at 37°C. After 1 hour, 175μl of an acid mixture containing sulfuric acid/
phosphoric acid/water (H2SO4/H3PO4/H2O) in a 1:3:7 ratio, was added to each well to stop the
enzymatic reaction. Urea was quantified calorimetrically at 540 nm after adding 1.25 μl of
1-phenyl-1,2-propanedione-2-oxime (ISPF) and heating at 95°C for 30–60 minutes. This pro-
cedure abrogates interference from other metabolites generated, such as L-citrulline [111].
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IL10, and IL12 were measured on the relevant cell supernatants using ELISA kits as previously
described [12]. For parasite growth assay, cells were either left unstimulated (control) or stimu-
lated with recombinant mouse IFNG (100 ng/ml, Peprotech) and TNF (100 ng/ml, AbD sero-
tec) for ~18 hr. The supernatant was removed for nitric oxide assay and replaced with D10
containing Toxoplasma at an MOI ~1. The parasites were allowed to infect and replicate for 24
hrs before luciferase activity was measured using a luciferase assay kit (Promega) according to
the manufacturer recommendations.
RNA sequencing
Primary BMDM were plated (3 x106) overnight before stimulation or infection. For the stimu-
lated samples, IFNG (100 ng/ml) and TNF (100 ng/ml) were added to each well for 18 hrs,
while for the infected samples, a type II strain of Toxoplasma (Pru) was added to the confluent
BMDM at an MOI of 1.3 for 8 hrs. Total RNA (Qiagen RNeasy Plus kit) was then isolated from
the non-stimulated and non-infected cells (controls plated overnight), stimulated, and infected
cells and the integrity, size, and concentration of RNA checked (Agilent 2100 Bioanalyser).
The mRNA was then purified by polyA-tail enrichment (Dynabeads mRNA Purification Kit;
Invitrogen), fragmented into 200–400 base-pairs, and reverse transcribed into cDNA before
Illumina sequencing adapters were added to each end. Libraries were barcoded, multiplexed
into 4 samples per sequencing lane in the Illumina HiSeq 2000, and sequenced from both ends
resulting in 40 bp reads after discarding the barcodes. Our preliminary RNA-seq experiments
with infected BMDM have shown that with 4 samples per lane, we still obtain enough read cov-
erage for reliable gene expression analysis.
Gene expression measurements
Reads were initially mapped to the mouse genome (mm9) and the Toxoplasma (ME49 v8.2)
genome using Bowtie (2.0.2) [112] and Tophat (v2.0.4) [66]. We then estimated gene expres-
sion levels in cufflinks (v2.0.0) [113] using the Illumina iGenomes refseq genome annotation
(NCBI build 37.2) with the multi-read, compatible-hits corrections and upper quantile normal-
ization options enabled. Because the reference genome to which we mapped the RNA-seq
reads is based on the C57BL/6J genomic sequence, and due to the known polymorphisms
between the AJ and C57BL/6J, we suspected that biases introduced at the read mapping stage
might affect our expression results. To mitigate this potential bias towards the reference allele,
we created a copy of the mouse genome in which all the known single nucleotide polymor-
phisms (SNPs) between AJ and B6, as annotated by the Wellcome Trust Sanger Institute
sequencing (ftp://ftp-mouse.sanger.ac.uk/current_snps/), were converted to a third (neutral)
nucleotide that is different from both the reference and AJ allele [67]. However, this did not
substantially change the average proportion of uniquely mapped reads or expression profiles of
individual genes in all the samples. In the end we used the mapping data generated from the
synthetic genome to quantify gene expression levels.
Quantitative Trait Locus (QTL) mapping
To map QTL, we used 934 AXB/BXA genetic informative markers obtained from http://www.
genenetwork.org. For all the in vitromeasurements and gene expression linkage analysis, a
genome-wide scan was performed using R/qtl [57]. Significance of QTL logarithm-of-odds
(LOD) scores was assessed using 1000 permutations of the phenotype data [114] and the corre-
sponding p-values reported. For the cellular phenotypes, QTL significance was reported at a
genome-wide threshold corresponding to p< 0.05. However, for eQTL mapping, we further
corrected for multiple testing on the multiple transcripts by using the p-values to estimate false
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discovery rate (FDR) in the qvalue package [115] and reported significant eQTL at
FDR 10%. To identify cis- and trans- eQTL, we computed the distance from the position of
the eQTL and the start of the physical location of the corresponding gene and designated any
eQTL located<10 Mb from the corresponding gene as cis, otherwise trans eQTL. The proce-
dure used to determine trans-bands has previously been described [25].
Validation of candidate regulators
We used shRNA to probe for functional or regulatory significance of some of the candidates
identified in our analysis. To do this, we used C57BL/6J immortalized bone marrow-derived
macrophages, described above. One day after plating, we added shRNA constructs containing
a puromycin resistance marker (RNAi Platform, Broad Institute) in the presence of 8 μg/ml
polybrene, followed by centrifugation at 800 x g for 2 hrs at 37°C. At the end of the spinfection,
the cells were incubated for an additional 24 hrs at 37°C in 5% CO2. The cells were then grown
in fresh cell culture medium for an additional 24 hrs before adding 4 μg/ml puromycin. Tran-
script knockdown was measured by quantitative reverse transcriptase polymerase chain reac-
tion (qRT-PCR) using the KAPA SYBR FAST Universal 2X qPCR Master Mix (KAPA
Biosystems) on a LightCycler qPCR instrument (Roche). Fold knockdown was measured using
the 2 delta-delta method [116] relative to LacZ-shRNA transduced cells. The puromycin-
selected cells were either left stimulated or stimulated with IFNG+TNF, as described above,
and the cell supernatant collected for nitric oxide assay.
Data access
The microarray data is available at the NCBI Gene Expression Omnibus archive under acces-
sion number GSE47046.
Supporting Information
S1 Table. A summary of the phenotypes measured in each stimulation.
(DOC)
S1 Fig. Macrophage phenotypes in AXB/BXA recombinant inbred mice. A) Parasite growth
(raw luciferase readout) in IFNG+TNF-stimulated BMDM, and B) Cellular amounts of NO in
IFNG+TNF-stimulated macrophages, C) Amount of Urea (Arginase enzyme activity) in IL-
4-stimulated BMDM, D) amount of IL-10 in LPS-stimulated BMDM, E) amount of IL-12 in
LPS-stimulated BMDM, and F) amount of CCL22 in CpG-stimulated BMDM, exhibit quanti-
tative trait quality. Three independent replicates; Mean (+SD)  p< 0.05 (Student’s t-test).
(EPS)
S2 Fig. Two loci with antagonistic effect modulate the amount of nitric oxide in IFNG+TNF-
stimulated macrophages. A) Primary genome-wide scans for the amount of NO produced in
BMDM stimulated with IFNG+TNF reveal loci on chromosome 4 and 12. B) Using the marker
at the NOmajor QTL on chromosome 12 as a covariate narrows the QTL peak on chromosome
4 (Red line). The effect of the two QTL on NO is antagonistic with the allele on C) chromosome
4 conferring higher amounts of NO in B6 BMDM, while D) the allele on chromosome 12 is asso-
ciated with lower amounts of NO in B6 BMDM.
(EPS)
S3 Fig. Correlating cellular amounts of nitric oxide (NO) with gene expression modules.
Using WGCNA, we constructed the co-expression modules for the genes in the resting (con-
trol) and IFNG+TNF-stimulated BMDM. A) The modules were then correlated with the
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amounts of NO in IFNG+TNF-stimulated BMDM. The correlation value for each module
(named as colors) is included in each box and the corresponding P value in brackets. The white
module showed the greatest correlation with NO in the IFNG+TNF-stimulated BMDM. B)
Shows the gene significance (correlation potential) of each gene in the white module with NO.
(EPS)
S4 Fig. Ddx1 and NO QTL co-localize on chromosome 4 and 12. A) The Ddx1 eQTL peak
(black) and NO QTL peak (red) co-localize on chromosome 4 and 12. B) Relative to the B6, the
AJ allele at the Ddx1 eQTL on chromosome 12 is correlated with low expression levels of Ddx1
(average expression across strains with each of the indicated genotype at this locus), but is C)
correlated with high amounts of NO in IFNG+TNF-stimulated BMDMs. D) Conversely, the
AJ allele at the Ddx1 eQTL on chromosome 4 is linked with higher expression of Ddx1 and E)
lower cellular amounts of NO in IFNG+TNF-stimulated BMDMs
(EPS)
S1 Dataset. Individual eQTL positions and candidate gene knockdown expression pheno-
types. Individual eQTL in: A) Resting macrophages, B) IFNG+TNF-stimulated macrophages,
C) CpG-stimulated macrophages, and D) Toxoplasma-infected macrophages. Datasets E)
shows a set of perturbed genes in macrophages with Irak4, Apobec1, Eya1, Rb1cc1, and Odc1
knockdown after IFNG+TNF stimulation, and F) shows the genes in the “white” module that
show correlation with the amount of NO produced in IFNG+TNF-stimulated macrophages.
(XLS)
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